Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−10.01 M USD
0.00 USD
12.10 M
About Akari Therapeutics Plc
Sector
Industry
CEO
Samir R. Patel
Website
Headquarters
Boston
Founded
2004
FIGI
BBG003PMV495
Akari Therapeutics Plc is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapeutics to treat orphan autoimmune and inflammatory diseases. Its lead product candidate, Nomacopan, is a second-generation complement inhibitor. The company was founded on October 7, 2004 and is headquartered in Boston, MA.
Displays a symbol's price movements over previous years to identify recurring trends.